Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between Absorica and medroxyprogesterone

Results for the following 2 drugs:
Absorica (isotretinoin)
medroxyprogesterone

Interactions between your drugs

Moderate

medroxyPROGESTERone ISOtretinoin

Applies to: medroxyprogesterone and Absorica (isotretinoin)

Using ISOtretinoin and medroxyPROGESTERone is not recommended. ISOtretinoin can cause severe, life-threatening birth defects if the mother takes the medication during pregnancy. Even one dose of ISOtretinoin can cause major birth defects of the baby's ears, eyes, face, skull, heart, and brain. Never use ISOtretinoin if you are pregnant. You must agree in writing to use two specific forms of birth control beginning 30 days before you start taking ISOtretinoin and ending 30 days after you stop taking it. Both a primary and a secondary form of birth control must be used together. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide